Meihao Medical Group Co., Ltd (HKG:1947)
Hong Kong · Delayed Price · Currency is HKD 0.5400
-0.0100 (-1.82%)
Sep 1, 2026, 2:18 PM HKT
Meihao Medical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 115.76 | 101.69 | 74.68 | 73.51 | 127.41 | 105.32 | |
Revenue Growth | 37.07% | 36.17% | 1.59% | -42.30% | 20.98% | 24.55% |
Cost of Revenue | 70.36 | 61.93 | 47.7 | 40.86 | 49.16 | 38.39 |
Gross Profit | 45.4 | 39.76 | 26.98 | 32.66 | 78.25 | 66.93 |
Selling, General & Admin | 65.35 | 60.42 | 59.79 | 43.6 | 35.71 | 22.6 |
Operating Expenses | 65.35 | 60.41 | 59.79 | 43.6 | 35.69 | 22.29 |
Operating Income | -19.95 | -20.65 | -32.81 | -10.95 | 42.56 | 44.64 |
Interest Expense | -0.3 | -0.53 | -1.62 | -1.63 | -1.89 | -2.47 |
Interest & Investment Income | 2.95 | 2.95 | 3.7 | 4.97 | 1.65 | 1.21 |
Currency Exchange Gain (Loss) | -1.44 | -1.44 | 0.11 | 0.06 | - | - |
Other Non Operating Income (Expenses) | -0.52 | 0.34 | 0.47 | 0.07 | -0.84 | 0.03 |
EBT Excluding Unusual Items | -19.26 | -19.34 | -30.15 | -7.48 | 41.49 | 43.41 |
Gain (Loss) on Sale of Investments | 0.7 | 0.7 | - | - | - | - |
Gain (Loss) on Sale of Assets | -0.42 | -0.42 | - | - | - | - |
Other Unusual Items | 2.92 | 2.92 | 0 | 0.32 | -1.28 | 0.26 |
Pretax Income | -16.06 | -16.14 | -30.15 | -7.16 | 40.2 | 43.67 |
Income Tax Expense | -2.34 | -1.99 | 2.48 | 6.45 | 11.63 | 11.49 |
Earnings From Continuing Operations | -13.72 | -14.15 | -32.62 | -13.61 | 28.57 | 32.18 |
Minority Interest in Earnings | -0.02 | -0.19 | 0.2 | 0.01 | -0.11 | -0.11 |
Net Income | -13.74 | -14.34 | -32.42 | -13.59 | 28.46 | 32.07 |
Net Income to Common | -13.74 | -14.34 | -32.42 | -13.59 | 28.46 | 32.07 |
Net Income Growth | - | - | - | - | -11.27% | 115.19% |
Shares Outstanding (Basic) | 594 | 582 | 582 | 600 | 457 | 450 |
Shares Outstanding (Diluted) | 594 | 582 | 582 | 600 | 457 | 450 |
Shares Change | 5.76% | -0.03% | -3.01% | 31.18% | 1.64% | - |
EPS (Basic) | -0.02 | -0.02 | -0.06 | -0.02 | 0.06 | 0.07 |
EPS (Diluted) | -0.02 | -0.02 | -0.06 | -0.02 | 0.06 | 0.07 |
EPS Growth | - | - | - | - | -12.70% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 6.07 | -19.75 | 0.05 | 24.17 | 28.6 |
Free Cash Flow Per Share | - | 0.01 | -0.03 | - | 0.05 | 0.06 |
Dividend Per Share | - | - | - | 0.009 | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 39.22% | 39.10% | 36.12% | 44.42% | 61.41% | 63.55% |
Operating Margin | -17.23% | -20.31% | -43.94% | -14.89% | 33.41% | 42.38% |
Profit Margin | -11.87% | -14.10% | -43.42% | -18.49% | 22.34% | 30.45% |
Free Cash Flow Margin | - | 5.97% | -26.45% | 0.07% | 18.97% | 27.16% |
EBITDA | -10.14 | -12.17 | -26.32 | -3.66 | 48.69 | 49.13 |
EBITDA Margin | -8.76% | -11.97% | -35.25% | -4.98% | 38.21% | 46.65% |
D&A For EBITDA | 9.81 | 8.48 | 6.49 | 7.29 | 6.13 | 4.49 |
EBIT | -19.95 | -20.65 | -32.81 | -10.95 | 42.56 | 44.64 |
EBIT Margin | -17.23% | -20.31% | -43.94% | -14.89% | 33.41% | 42.38% |
Effective Tax Rate | - | - | - | - | 28.93% | 26.31% |